Market Newsdesk

MCLEAN, Va., April 10, 2026 (GLOBE NEWSWIRE) — Cycurion, Inc. (Nasdaq: CYCU) (“Cycurion” or the “Company”), a leading provider of advanced IT cybersecurity solutions and AI-driven innovations for government, enterprise, and critical infrastructure clients, today continues to make it clear that it will not sit idly by and will vigorously investigate anyone involved in manipulating the price of the Company’s stock. In the latest step, Cycurion has issued litigation hold letters (formal evidence preservation) to 16 prominent market makers and securities firms, putting them on immediate notice to preserve all evidence of trading activity in the Company’s stock as part of an ongoing investigation into potential market manipulation.

The litigation hold letters, issued in connection with the Superior Court of Justice, Wake County, North Carolina (File No. 26CV012490-910) in the action Cycurion, Inc. f/k/a WAVS v. ACCESS Newswire Inc. and John Doe One, formally require each recipient to preserve and not destroy, alter, or delete any records related to trading in shares of Cycurion, Inc. (Nasdaq: CYCU) during the period February 16, 2026 through March 23, 2026. This includes all buy and sell orders, execution details, counterparty information, communications, customer account details (including KYC), surveillance reports, exception reports, internal investigations, margin and collateral records, order lifecycle data, bid/ask quotes, spread data, Consolidated Audit Trail information, and any Suspicious Activity Reports (SARs).

“As we have said from the beginning, we will not sit on our hands while others try to harm our company and our shareholders,” said Kevin Kelly, CEO of Cycurion. “We continue to make it clear that we will go after those who have hurt the Company and its shareholders by their nefarious actions. We are proactively issuing these litigation hold letters to 16 market makers as part of our investigation into potential short selling and market manipulation. Our internal cybersecurity team — with national security-level tradecraft — combined with targeted legal action, will continue to expose those responsible while we execute on our real business.”

Cycurion continues to focus on profitable growth and believes this will be a breakout year for the Company as it expands its contract backlog with government and enterprise clients, advances its proprietary ARx platform and AI-enhanced cybersecurity offerings, and delivers long-term value to shareholders.

This latest action builds upon the Company’s recent success in unmasking Michael S. Emo as the individual previously named as John Doe 1 and John Doe 2 in the Company’s defamation lawsuit pending in Alexandria, Virginia. Cycurion remains committed to using every available legal and technological tool to protect shareholder value, defend market integrity, and ensure the truth prevails.

About Cycurion, Inc.

Based in McLean, Virginia, Cycurion (NASDAQ: CYCU) is a forward-thinking provider of IT cybersecurity solutions and AI, committed to delivering secure, reliable, and innovative services to clients worldwide. Specializing in cybersecurity, program management, and business continuity, Cycurion harnesses its AI-enhanced ARx platform and expert team to empower clients and safeguard their operations. Along with its subsidiaries, Axxum Technologies LLC, Cloudburst Security LLC, and Cycurion Innovation, Inc., Cycurion serves government, healthcare, and corporate clients committed to securing the digital future. For more information, visit www.cycurion.com.

Forward-Looking Statements

This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the operations and prospective growth of Cycurion’s business.

Certain statements in this press release that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Such statements include, but are not limited to, statements regarding the anticipated closing of the offering; the Company’s anticipated use of proceeds from the offering; the acceleration of the Company’s inorganic growth strategy; the continued execution on the Company’s backlog; and other statements that are not historical facts, including statements which may be accompanied by words such as “continue,” “will,” “may,” “could,” “should,” “expect,” “expected,” “plans,” “intend,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” and similar expressions are intended to identify such forward-looking statements. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Cycurion and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to, the outcomes of the Company’s investigations, any potential legal proceedings, or the future performance of the Company’s stock. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K filed by Cycurion with the U.S. Securities and Exchange Commission. Cycurion anticipates that subsequent events and developments may cause its plans, intentions, and expectations to change. Cycurion assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as expressly required by law. Forward-looking statements speak only as of the date they are made and should not be relied upon as representing Cycurion’s plans and expectations as of any subsequent date.

Cycurion Investor Relations:
(888) 341-6680
[email protected]

Cycurion Media Relations:
(888) 341-6680
[email protected]

• Financing secures path to first NDA submission for buntanetap
• 6-Month symptomatic data readout anticipated Q1 2027
• Alzheimer’s disease Phase 3 trial 75% enrolled
• Parkinson’s disease open-label study 28% enrolled

MALVERN, Pa., April 10, 2026 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced the closing of an underwritten public offering raising approximately $10 million in gross proceeds. Combined with existing cash on hand as well as a recent $1.5 million investment from the Board of Directors Chair, Michael Hoffman, the financing extends Annovis’ cash runway through Q2 2027, fully funding the Company’s operations through a key symptomatic data readout of its Phase 3 AD trial and the anticipated submission of a New Drug Application (NDA) for buntanetap to the U.S. Food and Drug Administration (FDA).

“This financing is a decisive step forward for Annovis and for patients waiting for a novel Alzheimer’s treatment,” said Maria Maccecchini, Ph.D., President and CEO of Annovis. “We now have the resources to reach our first major regulatory milestone: the 6-month data readout from our Phase 3 AD trial and the NDA submission that follows. With enrollment nearing completion, NDA preparations launched, and an ongoing open-label study in PD, Annovis is executing on all fronts.”

Proceeds from this offering will primarily support the advancement of buntanetap through the pivotal Phase 3 AD trial (NCT06709014), which is approaching full enrollment with 75% of participants already enrolled. The trial is designed to provide two important milestones: a 6-month evaluation of symptomatic improvement and an 18-month assessment of potential disease modification, each followed by its own NDA submission. Preparations for the 6-month data readout and corresponding FDA filing are already underway.

Notably, the FDA has agreed to integrate safety data from both AD and PD populations from the Company’s completed and ongoing clinical trials in the NDA for AD, enabling regulatory efficiency that is expected to support a faster and more robust submission process.

In parallel, Annovis is conducting an open-label extension (OLE) study in PD patients (NCT07284784), which has enrolled 28% of participants since its inception in February 2026. The OLE study will test buntanetap for 36 months and capture safety, efficacy, and biomarker data. The OLE study also incorporates an AI-enabled digital biomarker device, developed and provided by NeuroRPM, that monitors symptom changes in real time, providing granular insight into buntanetap’s therapeutic effects and further differentiating Annovis’ clinical program.

About Annovis

Headquartered in Malvern, Pennsylvania, Annovis Bio, Inc. (NYSE: ANVS) is a Phase 3 clinical-stage biotechnology company developing treatments for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). The Company’s lead drug candidate, buntanetap (formerly posiphen), is an investigational once-daily oral therapy that inhibits the translation of multiple neurotoxic proteins, including APP and amyloid beta, tau, alpha-synuclein, and TDP-43, through a specific RNA-targeting mechanism of action. By addressing the underlying causes of neurodegeneration, Annovis aims to halt disease progression and improve cognitive and motor functions in patients. For more information, visit www.annovisbio.com and follow us on LinkedIn, YouTube, and X.

Investor Alerts

Interested investors and shareholders are encouraged to sign up for press releases and industry updates by registering for email alerts at https://www.annovisbio.com/email-alerts.

Forward-Looking Statements

This press release contains forward-looking statements under the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended. Actual results may differ due to various risks and uncertainties, including those outlined in the Company’s SEC filings under “Risk Factors” in its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no obligation to update forward-looking statements except as required by law.

Contact Information:

Annovis Bio Inc.
101 Lindenwood Drive
Suite 225
Malvern, PA 19355
www.annovisbio.com

Investor Contact:

Alexander Morin, Ph.D.
Director, Strategic Communications
Annovis Bio
[email protected]

MIAMI BEACH, Fla., April 10, 2026 (GLOBE NEWSWIRE) — Thomas J. Herzfeld Advisors, Inc., investment advisor to Herzfeld Credit Income Fund, Inc. (NASDAQ: HERZ) (the “Fund”), today announced the estimated net asset value (“NAV”) of the Fund as of March 31, 2026 was $19.78.

About Thomas J. Herzfeld Advisors, Inc.

Thomas J. Herzfeld Advisors, Inc., founded in 1984, is an SEC registered investment advisor, specializing in investment analysis and account management in closed-end funds. Thomas J. Herzfeld Advisors, Inc. serves as the investment advisor to Herzfeld Credit Income Fund, Inc. a publicly traded closed-end fund (NASDAQ: HERZ).

More information about the advisor can be found at www.herzfeld.com.

Past performance is no guarantee of future performance. An investment in the Fund is subject to certain risks, including market risk. In general, shares of closed-end funds often trade at a discount from their net asset value and at the time of sale may be trading on the exchange at a price which is more or less than the original purchase price or the net asset value. There can be no assurance that any Share repurchases will reduce or eliminate the discount of the Fund’s market price to the Fund’s net asset value per share. An investor should carefully consider the Fund’s investment objective, risks, charges and expenses. Please read the Fund’s disclosure documents before investing.

Forward-Looking Statements

This press release, and other statements that Thomas J. Herzfeld Advisors, Inc. (“TJHA”) or the Fund may make, may contain forward looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to the Fund’s or TJHA’s future financial or business performance, strategies or expectations. Forward-looking statements are typically identified by words or phrases such as “trend,” “potential,” “opportunity,” “pipeline,” “believe,” “comfortable,” “expect,” “anticipate,” “current,” “intention,” “estimate,” “position,” “assume,” “outlook,” “continue,” “remain,” “maintain,” “sustain,” “seek,” “achieve,” and similar expressions, or future or conditional verbs such as “will,” “would,” “should,” “could,” “may” or similar expressions. TJHA and the Fund caution that forward-looking statements are

subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and TJHA and the Fund assume no duty to and do not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and future results could differ materially from historical performance. With respect to the Fund, the following factors, among others, could cause actual events to differ materially from forward-looking statements or historical performance: (1) shares of the Fund may trade at a discount from Net Asset Value; (2) the Fund is expose to risks associated with equity and equity-linked securities to the extent that adverse equity market conditions could negatively impact the ability of the borrowers to make payment of interest and/or principal with respect to loans underlying the CLOS in which the Fund invests; (3) as a “non-diversified” investment company, the Fund’s investments involve greater risks than would be the case for a similar diversified investment company; (4) the Adviser’s judgment about the attractiveness, relative value or potential appreciation of a particular security or investment strategy may prove incorrect; (5) market disruption risks, including certain events that have had a disruptive effect on the securities markets, generally, such as pandemics, terrorist attacks, war and other geopolitical events, hurricanes, droughts, floods and other natural disasters; (6) risk of investment in CLOs and related securities generally; (7) dependence on managers of the CLOs in which the Fund invests; (8) risks associated with investing in CLOs generally. Annual and Semi-Annual Reports and other regulatory filings of the Fund with the SEC are accessible on the SEC’s website at

www.sec.gov

and on TJHA’s website at

www.herzfeld.com/herz

and may discuss these or other factors that affect the Fund. The information contained on TJHA’s website is not a part of this press release.

Contact:
Thomas Morgan
Chief Compliance Officer
Thomas J. Herzfeld Advisors, Inc.
1-305-777-1660

NEW YORK and SEOUL, South Korea, April 10, 2026 (GLOBE NEWSWIRE) — K Wave Media Ltd. (“KWM” or the “Company”) (NASDAQ: KWM), a global K-content, intellectual property (IP), and artificial intelligence (AI) technology platform, today announced via Form 6-K filed with the U.S. Securities and Exchange Commission that it has entered, through its wholly owned subsidiary Play Company Co., Ltd. (“Play Company”), into a global distribution agreement with HYBE for video and print merchandise related to 2026 concert activities. The agreement became effective on April 3, 2026, carries an initial term of one year, and may be extended upon mutual consent. The agreement encompasses not only BTS but also SEVENTEEN, LE SSERAFIM, and additional HYBE artists.

Under the agreement, KWM will distribute and monetize digital video products derived from BTS live concert performances to global audiences, including in the United States and key Asian markets. BTS is widely regarded as one of the most influential global music acts, with a substantial international fan base and strong consumer engagement.

The most significant component of this agreement centers on BTS. Prior to the group’s activity hiatus, BTS generated approximately $80 million in revenue in 2022 solely through video merchandising via Play Company. With all members having completed their mandatory military service and the 2026 world tour confirmed, market observers and analysts anticipate significant demand.

BTS’s fifth studio album, ARIRANG, has already surpassed four million pre-orders. The accompanying world tour, launching in Korea on April 9th, encompasses 79 confirmed performances over an 11-month run through March 2027, with additional dates anticipated in Japan, the Middle East, and other markets that could bring the total to between 90 and 100 shows. In January, tickets for 41 stadium performances across North America and Europe sold out immediately upon release, with venues in Madrid, Brussels, London, Munich, and Paris selling out within 60 minutes.

Industry analysts project the tour could generate approximately $1.45 billion (approximately KRW 2.14 trillion) in revenue, placing it alongside Taylor Swift and Coldplay among the world’s highest-grossing concert tours. The Guardian reported that “BTS’s world tour as a reunited group has the potential to generate an economic impact that surpasses Taylor Swift’s records.”

The Company expects the renewed collaboration to reestablish a scalable, fandom-driven revenue stream as BTS resumes global activities. KWM intends to leverage its existing production, localization, and distribution capabilities to expand monetization across multiple formats, including digital content, fan-focused commerce, and related offerings.

Play Company has an established track record of working with leading Korean entertainment companies to develop and distribute official K-pop content globally. The Company believes this agreement represents a meaningful step in strengthening its position within the global fandom economy and expanding its portfolio of high-value entertainment IP.

In addition, KWM recently completed the acquisitions of Rabbit Walk and a controlling interest in Inticube Co., Ltd., further expanding the Company’s content production and AI-driven engagement capabilities. These acquisitions are projected to increase KWM’s pro forma annual revenue by approximately 50–70%.

When combined with the recently completed acquisitions, KWM expects total incremental revenue contributions to exceed $50–$75 million on a pro forma basis, representing an estimated 50–70% increase relative to the Company’s prior revenue base. This growth is expected to propel the Company’s total revenue beyond $100 million over the next 12 months and enable the Company to turn profitable for the current fiscal year.

Ted Kim, Chief Executive Officer of KWM, stated: “We will continue to pursue strategic partnerships, investments, and acquisitions to expand our IP portfolio and develop an integrated platform that combines content, commerce, and technology.”

The Company expects to explore potential synergies between its global content IP and Inticube’s technology capabilities, with a focus on enhancing fan engagement, personalization, and digital commerce initiatives. KWM intends to continue developing new revenue streams beyond traditional content distribution, including data-driven services, digital goods, and platform-based monetization strategies.

About K Wave Media

K Wave Media (KWM) is a publicly listed entertainment and Bitcoin treasury company dedicated to creating, distributing, and monetizing high-quality content across multiple platforms. Since going public in 2025, KWM has focused on strategic growth initiatives, including acquisitions, digital platforms, and digital asset treasury management.

Through its subsidiaries, KWM currently works with major K-pop entertainment companies, including HYBE, SM Entertainment, JYP Entertainment, and KQ Entertainment.

Forward-Looking Statements

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “future,” “outlook,” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking.

These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other performance metrics and projections of market opportunity. These statements are based on various assumptions, whether or not identified in this communication, and on the current expectations of K Wave Media’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of K Wave Media. Some important factors that could cause actual results to differ materially from those in any forward-looking statements could include changes in domestic and foreign business, market, financial, political, and legal conditions.

If any of these risks materialize or K Wave Media’s assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that K Wave Media does not presently know, or that K Wave Media currently believes are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect K Wave Media’s current expectations, plans, and forecasts of future events and views as of the date hereof. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved.

You should not place undue reliance on forward-looking statements in this communication, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein and the risk factors of K Wave Media described in K Wave Media’s Form 20-F initially filed with the SEC on May 14, 2025, as amended, including those under “Risk Factors” therein. K Wave Media anticipates that subsequent events and developments will cause its assessments to change. However, while K Wave Media may elect to update these forward-looking statements at some point in the future, K Wave Media specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing K Wave Media’s assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Media Contact

Investor Relations: [email protected]
Public Relations: [email protected]